Paul Goode

CIK: 0001622251

Transaction Breakdown

Open Market Buys (P)2 (22.2%)

High conviction signal

Open Market Sales (S)0 (0.0%)

Position reduction

Option Exercises (M)0 (0.0%)

Derivative conversions

Awards (A)3 (33.3%)

Compensation grants

Other (G, F, J, C, D, …)4 (44.4%)

Gifts, tax withholding, conversions, dispositions to the issuer and other codes

Companies & Roles (1)

GCTK

Glucotrack, Inc.

DirectorOfficer

Discretionary Trading P&L

Holdings

Transaction History (9 total)

GCTK
Glucotrack, Inc.
Mar 25, 2025
Other(J)
Direct
42 shares-
GCTK
Glucotrack, Inc.
Mar 12, 2025
In-the-Money(X)
Direct
15.4K shares-
GCTK
Glucotrack, Inc.
Feb 5, 2025
Other(J)
Direct
1.5K shares-
GCTK
Glucotrack, Inc.
Nov 14, 2024
Award(A)
Series B Common Warrant
Direct
796 shares-
GCTK
Glucotrack, Inc.
Nov 14, 2024
Conversion(C)
Direct
796 shares at avg. $31.20$25K
GCTK
Glucotrack, Inc.
Nov 14, 2024
Award(A)
Series A Common Warrant
Direct
796 shares-
GCTK
Glucotrack, Inc.
Jul 18, 2024
Purchase(P)
Convertible Promissory Note
Direct
0 shares at avg. $10000.00-
GCTK
Glucotrack, Inc.
Jul 1, 2024
Purchase(P)
Warrants to Purchase Common Stock
Direct
2.1K shares-
GCTK
Glucotrack, Inc.
Jun 14, 2024
Award(A)
Stock option (right to buy)
Direct
3.3K shares-

		Type	Shares	Price		Ownership
Mar 25, 2025	GCTK Glucotrack, Inc.	Other(J)	42	-	-	Direct
Mar 12, 2025	GCTK Glucotrack, Inc.	In-the-Money(X)	15,435	-	-	Direct
Feb 5, 2025	GCTK Glucotrack, Inc.	Other(J)	1,500	-	-	Direct
Nov 14, 2024	GCTK Glucotrack, Inc.	Award(A) Series B Common Warrant	796	-	-	Direct
Nov 14, 2024	GCTK Glucotrack, Inc.	Conversion(C)	796	$31.20	$24,835	Direct
Nov 14, 2024	GCTK Glucotrack, Inc.	Award(A) Series A Common Warrant	796	-	-	Direct
Jul 18, 2024	GCTK Glucotrack, Inc.	Purchase(P) Convertible Promissory Note	0	$10000.00	-	Direct
Jul 1, 2024	GCTK Glucotrack, Inc.	Purchase(P) Warrants to Purchase Common Stock	2,100	-	-	Direct
Jun 14, 2024	GCTK Glucotrack, Inc.	Award(A) Stock option (right to buy)	3,277	-	-	Direct

1-9 of 9 transactions

About Goode Paul

Goode Paul (SEC CIK 0001622251) files insider reports with the SEC as Chief Executive Officer of Glucotrack, Inc. (GCTK).

Signal8 holds 2 ownership filings by Goode Paul, all Form 4s, filed between Mar 28, 2025 and Oct 7, 2025. Those filings report 9 transactions, from Jun 14, 2024 to Mar 25, 2025. Signal8's Form 4 history starts in Sep 2024.

The business address on Goode Paul's filings is in RUTHERFORD, NJ.

Recent filings by Goode Paul

Mar 25, 2025: Other transaction of GCTK shares (Form 4, code J).
Mar 12, 2025: Option exercise of GCTK shares (Form 4, code X).
Feb 5, 2025: Other transaction of GCTK shares (Form 4, code J).
Nov 14, 2024: Grant or award of GCTK derivative securities (Form 4, code A).
Nov 14, 2024: Conversion of GCTK shares (Form 4, code C).

Other insiders filing for Glucotrack, Inc. (GCTK)

CARR BRENDEL VICTORIA, Director
Balo Andrew K, Director
Malave Luis, Director
Carter Erin Catherine, Director
John A. Ballantyne Revocable Living Trust dated 08/01/2017, 10% Owner
BALLANTYNE JOHN, Director

How to read Form 4 transaction codes